Gilead Sciences Inc (GILD)
64.27
+0.19
(+0.30%)
USD |
NASDAQ |
May 31, 16:00
64.11
-0.16
(-0.25%)
After-Hours: 20:00
Gilead Sciences Cash and Short Term Investments (Annual): 7.264B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.264B |
| December 31, 2022 | 6.385B |
| December 31, 2021 | 6.52B |
| December 31, 2020 | 7.408B |
| December 31, 2019 | 24.35B |
| December 31, 2018 | 30.09B |
| December 31, 2017 | 25.51B |
| December 31, 2016 | 11.90B |
| December 31, 2015 | 14.61B |
| December 31, 2014 | 10.13B |
| December 31, 2013 | 2.132B |
| December 31, 2012 | 1.862B |
| December 31, 2011 | 9.900B |
| December 31, 2010 | 2.099B |
| December 31, 2009 | 1.657B |
| December 31, 2008 | 1.790B |
| December 31, 2007 | 1.172B |
| Date | Value |
|---|---|
| December 31, 2006 | 936.85M |
| December 31, 2005 | 2.311B |
| December 31, 2004 | 1.254B |
| December 31, 2003 | 707.00M |
| December 31, 2002 | 942.37M |
| December 31, 2001 | 582.85M |
| December 31, 2000 | 512.88M |
| December 31, 1999 | 294.39M |
| December 31, 1998 | 101.10M |
| December 31, 1997 | 32.00M |
| December 31, 1996 | 132.00M |
| December 31, 1995 | 27.40M |
| March 31, 1995 | 30.40M |
| March 31, 1994 | 13.00M |
| March 31, 1993 | 2.10M |
| March 31, 1992 | 87.90M |
| March 31, 1991 | 10.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
6.385B
Minimum
2022
24.35B
Maximum
2019
10.39B
Average
7.264B
Median
2023
Cash and Short Term Investments (Annual) Benchmarks
| Bristol-Myers Squibb Co | 12.28B |
| Merck & Co Inc | 7.093B |
| Pfizer Inc | 12.69B |
| AbbVie Inc | 12.82B |
| Xilio Therapeutics Inc | 44.70M |